BEIGENE SWITZERLAND GMBH has a total of 19 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are XYPHOS BIOSCIENCES INC, IMCHECK THERAPEUTICS SAS and SAGABIO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | China | 1 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Hungary | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Tong | 10 |
#2 | Peng Hao | 10 |
#3 | Xu Lanlan | 10 |
#4 | Li Kang | 10 |
#5 | Liu Qi | 10 |
#6 | Song Jing | 10 |
#7 | Feng Shibao | 3 |
#8 | Ro Sunhee | 3 |
#9 | Huang Jane | 3 |
#10 | Hilger James | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020249002A1 | Oral capsule and preparation method therefor | |
WO2020249001A1 | Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor | |
CN111801334A | Treatment of indolent or aggressive B-cell lymphomas using combinations comprising BTK inhibitors | |
US2019169201A1 | Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof | |
EP3044234A1 | Anti-pd1 antibodies and their use as therapeutics and diagnostics | |
SG10201912310WA | Anti-pd1 antibodies and their use as therapeutics and diagnostics |